Clinical trials have now finished, and Foundayo is in its regulatory stage, meaning it's waiting for approval to be sold in the UK and other countries
One study, completed in 2018, compared tirzepatide directly to dulaglutide: Results found that tirzepatide showed significantly better efficacy with regard to glucose control and weight loss than did dulaglutide, with an acceptable safety and tolerability profile. Side effects with tirzepatide were similar to those of dulaglutide and, in general, the drug was well tolerated
When we lose body fat quickly, our hormones shift, which can significantly impact the menstrual cycle, especially in the first few months on the medication when weight loss is typically greater
Kindly add products in your wishlist
The "Cuffing Sign": A defining characteristic, noted by Shavit et al
A new study reports that GLP-1 semaglutide medications may help reverse the effects of osteoarthritis in the joints